-
1
-
-
0035525733
-
Cellular stress response and apoptosis in cancer therapy
-
Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
-
(2001)
Blood
, vol.98
, pp. 2603-2614
-
-
Herr, I.1
Debatin, K.M.2
-
2
-
-
0034630167
-
Induction of apoptosis by cancer chemotherapy
-
Kaufmann SH and Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256: 42-49, 2000.
-
(2000)
Exp Cell Res
, vol.256
, pp. 42-49
-
-
Kaufmann, S.H.1
Earnshaw, W.C.2
-
3
-
-
31344468628
-
Structure-activity studies of quinuclidinone analogs as anti-proliferative agents in lung cancer cell lines
-
DOI 10.1016/j.bmcl.2005.11.085, PII S0960894X05015131
-
Malki A, Pulipaka A, Susan S and Bergmeier S: Structure activity studies of quinuclidinone analogs as antiproliferative agents in lung cancer cell lines. Bioorg Med Chem Lett 16: 1156-1159, 2006. (Pubitemid 43142982)
-
(2006)
Bioorganic and Medicinal Chemistry Letters
, vol.16
, Issue.5
, pp. 1156-1159
-
-
Malki, A.1
Pulipaka, A.B.2
Evans, S.C.3
Bergmeier, S.C.4
-
4
-
-
0027298576
-
Induction of cellular p53 activity by DNA-damaging agents and growth arrest
-
Zhan Q, Carrier F and Fornace AJ: Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13: 4242-4250, 1993. (Pubitemid 23187653)
-
(1993)
Molecular and Cellular Biology
, vol.13
, Issue.7
, pp. 4242-4250
-
-
Zhan, Q.1
Carrier, F.2
Fornace Jr., A.J.3
-
5
-
-
0028901034
-
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
-
Fan S, Smith ML and Rivet DJ: Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649-1654, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 1649-1654
-
-
Fan, S.1
Smith, M.L.2
Rivet, D.J.3
-
6
-
-
0030021996
-
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
-
Hawkins DS, Demers GW and Galloway DA: Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56: 892-898, 1996. (Pubitemid 26055483)
-
(1996)
Cancer Research
, vol.56
, Issue.4
, pp. 892-898
-
-
Hawkins, D.S.1
Demers, G.W.2
Galloway, D.A.3
-
7
-
-
79956089417
-
Differential effect of selected methylxanthine derivatives on radiosensitization and cell cycle of normal and lung cancer cell lines
-
Malki A and Susan S: Differential effect of selected methylxanthine derivatives on radiosensitization and cell cycle of normal and lung cancer cell lines. Exp Oncol 28(1): 18-24, 2006.
-
(2006)
Exp Oncol
, vol.28
, Issue.1
, pp. 18-24
-
-
Malki, A.1
Susan, S.2
-
8
-
-
0031263872
-
A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: A gene therapy approach for drug-resistant cancers
-
Seth P, Katayose D, Li Z, Kim, M., Wersto R, Craig C, Shanmugam N, Ohri E, Mudahar B, Rakkar AN, Kodali P and Cowan K: A recombinant adenovirus expressing wild-type p53 induces apoptosis in drag-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. Cancer Gene Ther 4: 383-390, 1997. (Pubitemid 127667131)
-
(1997)
Cancer Gene Therapy
, vol.4
, Issue.6
, pp. 383-390
-
-
Seth, P.1
Katayose, D.2
Li, Z.3
Kim, M.4
Wersto, R.5
Craig, C.6
Shanmugam, N.7
Ohri, E.8
Mudahar, B.9
Rakkar, A.N.S.10
Kodali, P.11
Cowan, K.12
-
10
-
-
0029962567
-
Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells
-
Yang B, Eshleman JR, Berger NA and Markowitz SD: Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells. Clinical Cancer Res 2: 1649-1657, 1996. (Pubitemid 26356347)
-
(1996)
Clinical Cancer Research
, vol.2
, Issue.10
, pp. 1649-1657
-
-
Yang, B.1
Eshleman, J.R.2
Berger, N.A.3
Markowitz, S.D.4
-
11
-
-
0035883628
-
Wild-type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression
-
Zhan M, Yu D, Lang A, Li L and Pollock RE: Wild-type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression. Cancer 92: 1556-1566, 2001.
-
(2001)
Cancer
, vol.92
, pp. 1556-1566
-
-
Zhan, M.1
Yu, D.2
Lang, A.3
Li, L.4
Pollock, R.E.5
-
12
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
-
(2000)
Cell
, vol.100
, Issue.1
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
13
-
-
0028265959
-
Lipid second messengers
-
DOI 10.1016/0092-8674(94)90148-1
-
Liscovitch M and Cantley LC: Lipid second messengers. Cell 77: 329-334, 1994. (Pubitemid 24145194)
-
(1994)
Cell
, vol.77
, Issue.3
, pp. 329-334
-
-
Liscovitch, M.1
Cantley, L.C.2
-
14
-
-
58149277751
-
Roles of bioactive sphingolipids in cancer biology and therapeutics
-
Saddoughi SA, Song P and Ogretmen B: Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 49: 413-440, 2008.
-
(2008)
Subcell Biochem
, vol.49
, pp. 413-440
-
-
Saddoughi, S.A.1
Song, P.2
Ogretmen, B.3
-
15
-
-
0030634437
-
Ceramide a novel lipid mediator of apoptosis
-
Smyth ML, Obeid LM and Hannun YA: Ceramide a novel lipid mediator of apoptosis. Adv Pharmacol 41: 133-154, 1997.
-
(1997)
Adv Pharmacol
, vol.41
, pp. 133-154
-
-
Smyth, M.L.1
Obeid, L.M.2
Hannun, Y.A.3
-
16
-
-
77951922837
-
Fine tuning of cell functions through remodeling of glycosphingolipids by plasma membrane-associated glycohydrolases
-
Sonnino S, Aureli M, Loberto N, Chigorno V and Prinetti A: Fine tuning of cell functions through remodeling of glycosphingolipids by plasma membrane-associated glycohydrolases. FEBS Lett 584: 1914-1922, 2010.
-
(2010)
FEBS Lett
, vol.584
, pp. 1914-1922
-
-
Sonnino, S.1
Aureli, M.2
Loberto, N.3
Chigorno, V.4
Prinetti, A.5
-
17
-
-
2442693091
-
Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells
-
DOI 10.1158/0008-5472.CAN-03-2787
-
Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, Laurent G, Gambert P, Solary E and Dimanche-Boitrel MT: Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 64(10): 3593-3598, 2004. (Pubitemid 38657937)
-
(2004)
Cancer Research
, vol.64
, Issue.10
, pp. 3593-3598
-
-
Lacour, S.1
Hammann, A.2
Grazide, S.3
Lagadic-Gossmann, D.4
Athias, A.5
Sergent, O.6
Laurent, G.7
Gambert, P.8
Solary, E.9
Dimanche-Boitrel, M.-T.10
-
18
-
-
0033786639
-
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy
-
Morita Y, Perez GI and Paris F: Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6(10): 1109-1114, 2000.
-
(2000)
Nat Med
, vol.6
, Issue.10
, pp. 1109-1114
-
-
Morita, Y.1
Perez, G.I.2
Paris, F.3
-
19
-
-
0032542763
-
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
-
Hwang D, Scollard D, Byrne J and Levine E: Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460, 1998. (Pubitemid 28160637)
-
(1998)
Journal of the National Cancer Institute
, vol.90
, Issue.6
, pp. 455-460
-
-
Hwang, D.1
Scollard, D.2
Byrne, J.3
Levine, E.4
-
20
-
-
0036156229
-
Cyclooxygenase-2 expression during carcinogenesis in the human stomach
-
DOI 10.1002/path.1033
-
van Rees BP, Saukkonen K and Ristimaki A: Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 196: 171-179, 2002. (Pubitemid 34110898)
-
(2002)
Journal of Pathology
, vol.196
, Issue.2
, pp. 171-179
-
-
Van Rees, B.P.1
Saukkonen, K.2
Ristimki, A.3
Polkowski, W.4
Tytgat, G.N.J.5
Drillenburg, P.6
Johan, A.O.G.7
-
21
-
-
0034900406
-
Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder
-
Shirahama T and Sakakura C: Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 7: 558-561, 2001. (Pubitemid 32707978)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.3
, pp. 558-561
-
-
Shirahama, T.1
Sakakura, C.2
-
22
-
-
0034671806
-
COX-2 is expressed in human pulmonary, colonic and mammary tumors
-
Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J and Koki AT: COX-2 is expressed in human pulmonary, colonic and mammary tumors. Cancer 89: 2537-2645, 2000.
-
(2000)
Cancer
, vol.89
, pp. 2537-2645
-
-
Soslow, R.A.1
Dannenberg, A.J.2
Rush, D.3
Woerner, B.M.4
Khan, K.N.5
Masferrer, J.6
Koki, A.T.7
-
23
-
-
0027993458
-
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
-
Eberhat CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994. (Pubitemid 24294584)
-
(1994)
Gastroenterology
, vol.107
, Issue.4
, pp. 1183-1188
-
-
Eberhart, C.E.1
Coffey, R.J.2
Radhika, A.3
Giardiello, F.M.4
Ferrenbach, S.5
DuBois, R.N.6
-
24
-
-
0034650771
-
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
-
Reddy BS, Hirose Y and Lubet R: Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60: 293-297, 2000. (Pubitemid 30070754)
-
(2000)
Cancer Research
, vol.60
, Issue.2
, pp. 293-297
-
-
Reddy, B.S.1
Hirose, Y.2
Lubet, R.3
Steele, V.4
Kelloff, G.5
Paulson, S.6
Seibert, K.7
Rao, C.V.8
-
25
-
-
0033591794
-
Early trials probe COX-2 inhibitors' cancer-fighting potential
-
Ziegler J: Early trials probe COX-2 inhibitors' cancer-fighting potential. J Natl Cancer Inst 91: 1186-1187, 1999.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1186-1187
-
-
Ziegler, J.1
-
26
-
-
24644523517
-
The role of caspases in cell death and differentiation
-
DOI 10.1016/j.drup.2005.05.001, PII S1368764605000440
-
Oliver L and Vallette FM: The role of caspases in cell death and differentiation. Drag Resist Updat 8(3): 163-170, 2005. (Pubitemid 41267066)
-
(2005)
Drug Resistance Updates
, vol.8
, Issue.3
, pp. 163-170
-
-
Oliver, L.1
Vallette, F.M.2
-
27
-
-
0242432345
-
Many cuts to rain: A comprehensive update of caspase substrates
-
Fischer U, Janicke RU and Schulze-Osthoff K: Many cuts to rain: a comprehensive update of caspase substrates. Cell Death Differ 10(1): 76-100, 2003.
-
(2003)
Cell Death Differ
, vol.10
, Issue.1
, pp. 76-100
-
-
Fischer, U.1
Janicke, R.U.2
Schulze-Osthoff, K.3
-
28
-
-
0037252734
-
Epidemiology of lung cancer
-
Alberg AJ and Samet JM: Epidemiology of lung cancer. Chest J 123(1 Suppl): 21S-49S, 2003.
-
(2003)
Chest J
, vol.123
, Issue.1 SUPPL.
-
-
Alberg, A.J.1
Samet, J.M.2
-
29
-
-
2442543093
-
Genetic predisposition to lung cancer
-
Schwartz AG: genetic predisposition to lung cancer. Chest 125(5 Suppl): 86S-89S, 2004.
-
(2004)
Chest
, vol.125
, Issue.5 SUPPL.
-
-
Schwartz, A.G.1
-
30
-
-
0032011418
-
Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells
-
Adachi H, Preston G, Harvat B, Dawson MI and Jetten AM: Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am J Respir Cell Mol Biol 18(3): 323-233, 1998.
-
(1998)
Am J Respir Cell Mol Biol
, vol.18
, Issue.3
, pp. 323-1233
-
-
Adachi, H.1
Preston, G.2
Harvat, B.3
Dawson, M.I.4
Jetten, A.M.5
-
33
-
-
0037108873
-
2-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1
-
Yu Q, La Rose J, Zhang H, Takemura H, Kohn KW and Pommier Y: UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. Cancer Res 62: 5743-5748, 2002. (Pubitemid 35204730)
-
(2002)
Cancer Research
, vol.62
, Issue.20
, pp. 5743-5748
-
-
Yu, Q.1
La, R.J.2
Zhang, H.3
Takemura, H.4
Kohn, K.W.5
Pommier, Y.6
-
34
-
-
0032126541
-
Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines
-
Aldridge DR and Radford IR: Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res 58: 2817-2824, 1998. (Pubitemid 28311913)
-
(1998)
Cancer Research
, vol.58
, Issue.13
, pp. 2817-2824
-
-
Aldridge, D.R.1
Radford, I.R.2
-
36
-
-
1842600898
-
Animal cell cycles and their control
-
Nobury C and Nurse P: Animal cell cycles and their control. Trends Biochem Sci 19: 143-145, 1992.
-
(1992)
Trends Biochem Sci
, vol.19
, pp. 143-145
-
-
Nobury, C.1
Nurse, P.2
-
37
-
-
0028964917
-
FAS-induced apoptosis is mediated via ceramide-initiated RAS signaling pathway
-
Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C and Lang F: FAS-induced apoptosis is mediated via ceramide-initiated RAS signaling pathway. Immunity 2(4): 341-351, 1995.
-
(1995)
Immunity
, vol.2
, Issue.4
, pp. 341-351
-
-
Gulbins, E.1
Bissonnette, R.2
Mahboubi, A.3
Martin, S.4
Nishioka, W.5
Brunner, T.6
Baier, G.7
Baier-Bitterlich, G.8
Byrd, C.9
Lang, F.10
-
38
-
-
0028855405
-
Ceramide: An intracellular signal for apoptosis
-
Hannun YA and Obeid LM: Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 20(2): 73-77, 1995.
-
(1995)
Trends Biochem Sci
, vol.20
, Issue.2
, pp. 73-77
-
-
Hannun, Y.A.1
Obeid, L.M.2
-
39
-
-
0028078720
-
Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway
-
DOI 10.1073/pnas.91.1.73
-
Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA and Grant S: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91(1): 73-77, 1994. (Pubitemid 24018645)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.1
, pp. 73-77
-
-
Jarvis, W.D.1
Kolesnick, R.N.2
Fornari, F.A.3
Traylor, R.S.4
Gewirtz, D.A.5
Grant, S.6
-
40
-
-
3042836326
-
COX-2 inhibition and lung cancer
-
Sandler AB and Dubinett SM: COX-2 inhibition and lung cancer. Semin Oncol 31(2): 45-52, 2004.
-
(2004)
Semin Oncol
, vol.31
, Issue.2
, pp. 45-52
-
-
Sandler, A.B.1
Dubinett, S.M.2
-
41
-
-
0030589376
-
2 Enhance Peripheral Blood Lymphocyte IL-10 Transcription and Protein Production
-
2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 157: 5512-5520, 1996. (Pubitemid 126448972)
-
(1996)
Journal of Immunology
, vol.157
, Issue.12
, pp. 5512-5520
-
-
Huang, M.1
Sharma, S.2
Mao, J.T.3
Dubinett, S.M.4
-
42
-
-
0032533858
-
Expression of cyclooxygenase-2 in human lung carcinoma
-
Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H and Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58: 4997-5001, 1998. (Pubitemid 28521147)
-
(1998)
Cancer Research
, vol.58
, Issue.22
, pp. 4997-5001
-
-
Wolff, H.1
Saukkonen, K.2
Anttila, S.3
Karjalainen, A.4
Vainio, H.5
Ristimaki, A.6
-
43
-
-
12144291145
-
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines, ENA-78/CXCL5 and IL-8/CXCL8, in human non-small cell lung cancer
-
Põld M, Zhu LX, Sharma S, Burdek, M, Lin Y, Pold A, Krysan A, Moa J, Batra R, Strieter, R and Dubinet S: Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines, ENA-78/CXCL5 and IL-8/CXCL8, in human non-small cell lung cancer. Cancer Res 64: 1853-1860, 2004.
-
(2004)
Cancer Res
, vol.64
, pp. 1853-1860
-
-
Põld, M.1
Zhu, L.X.2
Sharma, S.3
Burdek, M.4
Lin, Y.5
Pold, A.6
Krysan, A.7
Moa, J.8
Batra, R.9
Strieter, R.10
Dubinet, S.11
-
44
-
-
0036792206
-
Celecoxib, a selective clooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neuinduced breast cancer
-
Howe LR, Subbaramaiah K, Patel J, Masferrer KL, Deora A, Hudis C, Thaler HT, Muller W, Du, Brown A and Dannenberg AJ: Celecoxib, a selective clooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neuinduced breast cancer. Cancer Res 62: 5405-5417, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 5405-5417
-
-
Howe, L.R.1
Subbaramaiah, K.2
Patel, J.3
Masferrer, K.L.4
Deora, A.5
Hudis, C.6
Thaler, H.T.7
Muller, W.8
Du9
Brown, A.10
Dannenberg, A.J.11
-
45
-
-
0036716281
-
The BCL2 family: Regulators of the cellular life-or-death switch
-
DOI 10.1038/nrc883
-
Cory S and Adams JM: The Bcl2 family: regulators of the cellular life or death switch. Nat Rev Cancer 2: 647-656, 2002. (Pubitemid 37328916)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.9
, pp. 647-656
-
-
Cory, S.1
Adams, J.M.2
|